Xeragenx LLC

xeragenx is a plant sciences company developing and commercializing advanced prescription and nutritional products for unmet therapeutic needs. the company has technology and expertise for extracting recombinant proteins expressed in genetically modified plants and is advancing multiple applications for their commercial use. the company’s lead therapeutic compound is for the maintenance treatment of vitamin b12 deficiency via the body’s physiologic absorption pathway. normal physiologic absorption of vitamin b12 requires it being bound to and protected by the native human protein intrinsic factor for receptor-targeted delivery and release into the bloodstream. xeragenx is developing a purified recombinant form of human intrinsic factor (rhif) that is pre-bound to vitamin b12 for oral administration, ensuring consistent and reliable receptor-targeted absorption with the ideal physiologic dose. xeragenx is also advancing development programs that utilize the rhif protein with b12 and/or